Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Clinical trial NCT04340388 · COMPLETED

Trial details

NCT number: NCT04340388
Sponsor: Augusta University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1-infection Antiviral Drug Adverse Reaction Vascular Diseases Cardiovascular Abnormalities Abnormality of Adipose Tissue Body Weight Changes Body Fat Disorder HIV-Associated Lipodystrophy Syndrome

Start date: 2020-09-17
Primary completion: 2022-06-17
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.